Enhanced CRISPR lets scientists explore all steps of health and disease in every cell type

29 Nov 2016

Researchers from the Wellcome Trust Sanger Institute and the University of Cambridge have created sOPTiKO, a more efficient and enhanced inducible CRISPR genome editing platform. Today, in the journal Development, they describe how the freely available single-step system works in every cell in the body and at every stage of development. This new approach will aid researchers in developmental biology, tissue regeneration and cancer.

Read More

Pain in the machine: a Cambridge Shorts film

02 Nov 2016

The pain we experience as humans has physical and emotional components. Could we develop a machine that feels pain a similar way – and would we want to? The first of four Cambridge Shorts looks at the possibilities and challenges.

Read More

Pages